817 research outputs found

    I2PA, U-prove, and Idemix: An Evaluation of Memory Usage and Computing Time Efficiency in an IoT Context

    Full text link
    The Internet of Things (IoT), in spite of its innumerable advantages, brings many challenges namely issues about users' privacy preservation and constraints about lightweight cryptography. Lightweight cryptography is of capital importance since IoT devices are qualified to be resource-constrained. To address these challenges, several Attribute-Based Credentials (ABC) schemes have been designed including I2PA, U-prove, and Idemix. Even though these schemes have very strong cryptographic bases, their performance in resource-constrained devices is a question that deserves special attention. This paper aims to conduct a performance evaluation of these schemes on issuance and verification protocols regarding memory usage and computing time. Recorded results show that both I2PA and U-prove present very interesting results regarding memory usage and computing time while Idemix presents very low performance with regard to computing time

    Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease

    Get PDF
    New technologies have greatly shaped the scientific and medical landscape within the last years. The unprecedented expansion of data and information on RNA biology has led to the discovery of new RNA classes with unique functions and unexpected modifications. Today, the biggest challenge is to transfer the large number of findings in basic RNA biology into corresponding clinical RNA-based therapeutics. Lately, this research begins to yield positive outcomes. RNA drugs advance to the final phases of clinical trials or even receive FDA approval. Furthermore, the introduction of the RNA-guided gene-editing technology CRISPR and advances in the delivery ofmessenger RNAs have triggered a major progression in the field of RNA-therapeutics. Especially short interfering RNAs and antisense oligonucleotides are promising examples for novel categories of therapeutics. However, several issues need to be addressed including intracellular delivery, toxicity, and immune responses before utilizing RNAs in a clinical setting. In this review, we provide an overview on opportunities and challenges for clinical translation of RNA-based therapeutics, with an emphasis on advances in novel delivery technologies and abdominal aortic aneurysm disease where non-coding RNAs have been shown to play a crucial regulatory role

    Texture and Microstructure in Hot-Pressed Si

    Get PDF
    • …
    corecore